118 related articles for article (PubMed ID: 7652759)
1. Comparison of panel-reactive antibody levels in Caucasian and African American renal transplant candidates.
Cooper TY; Jordan CL; Willimon CM; Land GA
Transplantation; 1995 Aug; 60(4):327-30. PubMed ID: 7652759
[TBL] [Abstract][Full Text] [Related]
2. Immunogenetic factors that may contribute to ethnic differences in renal allograft survival.
Ward FE; MacQueen JM
Clin Transplant; 1996 Dec; 10(6 Pt 2):620-4. PubMed ID: 8996754
[TBL] [Abstract][Full Text] [Related]
3. Influence of race on crossmatch outcome and recipient eligibility for transplantation.
Kerman RH; Kimball PM; Van Buren CT; Lewis RM; Cavazos D; Heydari A; Kahan BD
Transplantation; 1992 Jan; 53(1):64-7. PubMed ID: 1733088
[TBL] [Abstract][Full Text] [Related]
4. Kidney allograft survival of African American and Caucasian American recipients with lupus.
Contreras G; Li H; Gonzalez-Suarez M; Isakova T; Scialla JJ; Pedraza F; Mattiazzi A; Diaz-Wong R; Sageshima J; Brito Y; Guerra G; Acevedo B; Sajid Ali A; Kershaw TJ; Chen L; Burke GW; Kupin W; Ciancio G; Roth D
Lupus; 2014 Feb; 23(2):151-8. PubMed ID: 24297643
[TBL] [Abstract][Full Text] [Related]
5. The UNOS Scientific Renal Transplant Registry.
Cecka JM
Clin Transpl; 1996; ():1-14. PubMed ID: 9286555
[TBL] [Abstract][Full Text] [Related]
6. HLA phenotypes of ESRD patients are risk factors in the panel-reactive antibody (PRA) response.
Heise E; Manning C; Thacker L
Clin Transplant; 2001; 15 Suppl 6():22-7. PubMed ID: 11903382
[TBL] [Abstract][Full Text] [Related]
7. Blacks as donors for transplantation: suboptimal outcomes overcome by transplantation into other minorities.
Callender CO; Cherikh WS; Miles PV; Hermesch A; Maddox G; Nash J; Hernandez A; Burston B
Transplant Proc; 2008 May; 40(4):995-1000. PubMed ID: 18555098
[TBL] [Abstract][Full Text] [Related]
8. Center-level factors and racial disparities in living donor kidney transplantation.
Hall EC; James NT; Garonzik Wang JM; Berger JC; Montgomery RA; Dagher NN; Desai NM; Segev DL
Am J Kidney Dis; 2012 Jun; 59(6):849-57. PubMed ID: 22370021
[TBL] [Abstract][Full Text] [Related]
9. Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease.
Sawaya BP; Butros R; Naqvi S; Geng Z; Mawad H; Friedler R; Fanti P; Monier-Faugere MC; Malluche HH
Kidney Int; 2003 Aug; 64(2):737-42. PubMed ID: 12846773
[TBL] [Abstract][Full Text] [Related]
10. The race effect.
Yuge J; Cecka JM
Clin Transpl; 1989; ():407-16. PubMed ID: 2487609
[TBL] [Abstract][Full Text] [Related]
11. The HLA-matching effect in different cohorts of kidney transplant recipients: 10 years later.
Sasaki N; Idica A
Clin Transpl; 2010; ():261-82. PubMed ID: 21696046
[TBL] [Abstract][Full Text] [Related]
12. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group.
Neylan JF
Transplantation; 1998 Feb; 65(4):515-23. PubMed ID: 9500626
[TBL] [Abstract][Full Text] [Related]
13. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
14. Potential risk factors for hypersensitization reflected by panel-reactive antibodies in dialysis patients.
Pour-Reza-Gholi F; Daneshvar S; Nafar M; Firouzan A; Farrokhi F; Einollahi B
Transplant Proc; 2005 Sep; 37(7):2936-8. PubMed ID: 16213266
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women.
Dignam JJ
J Natl Cancer Inst Monogr; 2001; (30):36-43. PubMed ID: 11773290
[TBL] [Abstract][Full Text] [Related]
16. Disproportionate HLA matching may contribute to racial disparity in patient survival following cardiac transplantation.
Park MH; Tolman DE; Kimball PM
Clin Transplant; 1996 Dec; 10(6 Pt 2):625-8. PubMed ID: 8996755
[TBL] [Abstract][Full Text] [Related]
17. Influence of race in heart failure and cardiac transplantation: mortality differences are eliminated by specialized, comprehensive care.
Pamboukian SV; Costanzo MR; Meyer P; Bartlett L; McLeod M; Heroux A
J Card Fail; 2003 Apr; 9(2):80-6. PubMed ID: 12751127
[TBL] [Abstract][Full Text] [Related]
18. Significance of panel reactive antibodies in patients requiring kidney transplantation.
Mishra MN; Baliga KV
Saudi J Kidney Dis Transpl; 2013 May; 24(3):495-9. PubMed ID: 23640620
[TBL] [Abstract][Full Text] [Related]
19. Effect of mycophenolate mofetil on long-term outcomes in African american renal transplant recipients.
Meier-Kriesche HU; Ojo AO; Leichtman AB; Punch JD; Hanson JA; Cibrik DM; Kaplan B
J Am Soc Nephrol; 2000 Dec; 11(12):2366-2370. PubMed ID: 11095660
[TBL] [Abstract][Full Text] [Related]
20. Successful renal transplantation in American Indians.
Kasiske BL; Chakkera H
Transplantation; 1998 Jul; 66(2):209-14. PubMed ID: 9701266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
